Brief: ISR: Start Of Drug Study For HIV Patients Approved In Germany

ISR Immune System Regulation Holding AB (publ)

13/10/2020 16:02

Oct 13 (Reuters) - ISR Immune System Regulation Holding AB
(publ)  ISR.ST :
    * START OF DRUG STUDY FOR HIV PATIENTS APPROVED IN GERMANY
    * ISR'S DRUG STUDY ISR003 HAS TODAY BEEN APPROVED BY THE
ETHICS
COMMITTEE AND THE SWEDISH MEDICINES AGENCY TO BEGIN INCLUSION OF
HIV-INFECTED PATIENTS
    * PATIENT INCLUSION IS EXPECTED TO BEGIN WITHIN A WEEK

Source text for Eikon:  ID:nWkr3lZ16Q 
Further company coverage:  ISR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))